MAPT and Alzheimer disease: It has been suggested that at the onset of AD, the intra-neuronal accumulation of β-amyloid causes a slight decrease in CX3CL1/CX3CR1 signaling, resulting in increased Aβ phagocytosis and the hyperphosphorylation of tau [4].